This article is forms part of a special issue on "research on prevention and control of emerging infectious diseases" https://www.sciencedirect.com/journal/biosafety-and-health/vol/4/issue/4.
The COVID-19 pandemic has highlighted the practice of infectious diseases biobanking, as well as existing challenges and opportunities.
Governance frameworks allowing for the sharing of materials and data, the plurarity of sample collection and storing SOPs and the adherence to biosafety level requirements were highlighted as potential operational barriers.
The availability of an increased number of purpose-built biobanks with harmonized SOPs, allows for scalability of response in times of crisis.
Collaborations of infectious disease biobanks with existing vertical national and regional efforts provide synergistic opportunities that can positively impact biobank sustainability, staff training and retention.
Keywords: Biobanks, COVID-19, Biobank standards, Biobank best practices, Biobank networks
# # # # # #
Biosafety and Health is sponsored by the Chinese Medical Association, managed by National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC).
For more information, please visit https://www.journals.elsevier.com/biosafety-and-health
Biosafety and Health is available on ScienceDirect (https://www.sciencedirect.com/journal/biosafety-and-health).
Submissions to Biosafety and Health may be made using Editorial Manager® (https://www.editorialmanager.com/bsheal/default.aspx).
# # # # # #
Article reference: Balwir Matharoo-Ball, Mbayame Diop, Zisis Kozlakidis, Harmonizing the COVID-19 sample biobanks: Barriers and opportunities for standards, best practices and networks, Biosafety and Health, Volume 4, Issue 4, 2022, Pages 280-282, ISSN 2590-0536, https://doi.org/10.1016/j.bsheal.2022.06.003.